CureVac - Hauptforum Forum: Community User: NeulingImDAX

Da es ein riesen Beitrag ist, "spamme" ich den nicht hier rein. Aber gerade wurden 2 News von BioNtech per Mail verschickt, welche m.M.m. nach ganz klar Curevac weiter ins Aus katapultieren! Kein Populismus, nüchterne Analyse. Die ausführliche Erklärung hier: https://www.boersennews.de/community/diskussion/daytrader-biontech/49944/ Clickbait: BioNtech verkauft die 500Mio Dosen an die USA zum Selbstkostenpreis!

luciman heute 13:41 Uhr.... I tend not to take notice of what Analysts say- reason for this is they work for different entity's and are paid that way. The study data so far out of Argentina focuses on a particular variant of major concern - only second to the New Indian variant- its a variant where Pfizer vaccine is still only showing 64% efficacy. The Uk rate based on what they call a R Number must not exceed 1.00 its currently at 1.65 on people under 45 years of age. but there as been a jump to 1.83 on people over 65- and that is down to mixing vaccine- escapes from Vaccines . the Northwest of the UK as some awful number on Delta the Indian variant and the symptoms have changed from a Person being very poorly to a person who just shows a cough and runny nose. The UK Chancellor of the exchequer came out and said they would not go to the next stage of unlocking on June 21 st and have reinforced international flights from Portugal - and other countries. Then you have Latin America which you simply can not vaccinate everyone. What staggers me is how EU citizens think that mixing vaccines and taking the first vaccines protect- well they do- but the variants break through especially the P1 variant out of Brazil... In the middle east UAE-QATAR-OMAN-BAHRAIN are all using GSK monoclonal Antibody's on people vaccinated with Pfizer due to what is occurring - and the UK I read today is rushing to get GSK Curevac booster vaccine for people ready for September- the UK is an Odd place- but Capitalism rules and they know what is coming this Fall

Jonathan woher hast du diese Info bezüglich der 95% auf Curevac

Danke John, danke luciman für die interessanten Informationen. Bin geneigt nachzukaufen.

Ocugen gerade minus 42% da knallt es gerafe

Berenberg Bank bleibt auch in der aktuellen Einschätzung beim buy-rating für Curevac!

The efficacy of CureVac's Covid-19 vaccine is still hard to determine but is set to remain in focus as critical data from the phase 3 trial is expected this month, Berenberg says. Analysts at the bank say the trial's progress seems encouraging and could facilitate a rapid regulatory discussion in the coming months. They expect the CVnCoV vaccine to be 70% to 80% effective, also considering variant strains are now dominant and pose a significant threat to current vaccines. "We do not expect substantial roadblocks with regard to authorization in the EU, if efficacy clears the regulatory bar," says Berenberg. "While the company did not provide details of the interactions with regulators, we think the hope for 3Q approval largely remains intact."

Regarding the symptoms of the vaccine, the director explained that "there were some minor manifestations such as low-grade fever, muscle aches, the usual of a vaccine." In addition, he highlighted that severe allergic reactions were not recorded either. " The study had opened the registration for 9 thousand volunteers in different parts of the Province, a center in Rosario and another in CABA. Among them, some received both doses of the vaccine to be tested, while others were inoculated with a placebo. In addition, not only the German company is carrying out the studies in Berazategui, but they are also working in two public hospitals in the province of Buenos Aires: the Vicente López y Planes de General Rodríguez Hospital, and the Ramón Carrillo de Tres de Febrero .

Now the vaccine is in phase 3 in different countries around the world. For example, in Argentina, the Buenos Aires Ministry of Health opened registration to participate in clinical trials on March 8, under the general coordination of the Evita Pueblo hospital in Berazategui. Juan Marini, executive director of the hospital, indicated that “the protocol has a 13-month follow-up, although it may continue until two years. We assume that in the first days of Junethe study will be approved in Europe. From there, it will be easy for the ANMAT to approve it ”.

In phase 3. The Curevac vaccine was 95% effective The German Curevac vaccine, which is being tested in the suburbs, showed great efficacy and is expected to be approved this month. June 08, 2021 - 1:10 PM Studies of the German vaccine , Curevac , in Argentina, showed an efficacy of 95% where the research headquarters is located in Berazategui and it is expected to be approved this month. The results of the formula used by the biopharmaceutical company confirmed the 95% efficacy of the vaccine against the SARS-CoV-2 virus, 28 days after the first dose and seven days after the second. They report that the Curevac vaccine appears to be "very well positioned" and was developed with the support of the German government and the European Community, and successfully completed phase 1 and phase 2 trials.

Ich vermute mal bei Spahn waren keine Fragen zu CureVac erlaubt, anders kann ich mir das nicht erklären :D

Enjoy reading- it gives faith in everything outside D land https://tec.mx/en/news/national/health/mexican-curevac-vaccine-studies-move-ahead-tecsalud

Opio, am besten besprichst Du das mit deinem Arzt. Der kann ja auch einen Antikörpertest machen und prüfen, ob die bereits über ausreichend Schutz verfügst. Außerdem könntes Du ja auch im Herbst noch einmal eine Auffrischungsimpfung machen. Aber bitte nichts ohne den Arzt zuvor gefragt zu haben. Ich selbst habe mir im Übrigen bereits alles reindrücken lassen, was auf dem Markt ist. Die Überdosis hat mir offensichtlich nicht geschadet. Aber ich habe noch keinen einzigen Antikörper bei mir gefunden außer LOONA!

@Tycoon...Lese dir bitte den Verlauf durch. Es geht nicht um die Aktie sondern den Impfstoff.

Latest details from the UK show 80 year olds and upwards who were first vaccinated - are now going down with the virus and they had Pfizer- as it was the first vaccine authorised and given in December 2020- study the numbers- the cases are spiking upwards again- and so are those over 70 years of age having the same clinical issues and now lined up for first booster in September- if they are still alive by then

Stay bullshit, machst du hier Werbung für BionTech?